Publication Name	World Journal of Cardiology
Manuscript ID	19311
Country	France

Received	2015-05-08 16:11
Peer-Review Started	2015-05-12 17:28
To Make the First Decision	2015-07-27 18:44
Return for Revision	2015-07-29 17:59
Revised	2015-08-03 18:34
Second Decision	2016-01-15 16:02
Accepted by Journal Editor-in-Chief	2016-01-16 01:55
Accepted by Executive Editor-in-Chief	2016-01-22 16:24
Articles in Press	2016-01-22 16:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-05-05 16:20
Publish the Manuscript Online	2016-05-20 11:59

ISSN	1949-8462 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Minireviews
Article Title	P2Y12-ADP receptor antagonists: Days of future and past
Manuscript Source	Invited Manuscript
All Author List	Marc Laine, Franck Paganelli and Laurent Bonello
Funding Agency and Grant Number
Corresponding Author	Marc Laine, MD, Cardiology Department, CHU NORD, Chemine des Bourrely, AP-HM, 13015 Marseille, France. marc.laine@ap-hm.fr
Key Words	Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome; Ticagrelor; Cangrelor
Core Tip	Antiplatelet therapy in coronary artery disease has dramatically changed during the past few years. From ticlodipine to cangrelor, the present review summarizes the results of the main studies dealing with this hot topic of cardiology.
Publish Date	2016-05-20 11:59
Citation	Laine M, Paganelli F, Bonello L. P2Y12-ADP receptor antagonists: Days of future and past. World J Cardiol 2016; 8(5): 327-332
URL	http://www.wjgnet.com/1949-8462/full/v8/i5/327.htm
DOI	http://dx.doi.org/10.4330/wjc.v8.i5.327

Full Article (PDF)	WJC-8-327.pdf
Full Article (Word)	WJC-8-327.doc
Manuscript File	19311-Review.docx
Answering Reviewers	19311-Answering reviewers.pdf
Audio Core Tip	19311-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19311-Conflict-of-interest statement.pdf
Copyright License Agreement	19311-Copyright assignment.pdf
Peer-review Report	19311-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	19311-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	19311-Scientific misconduct check.pdf
Scientific Editor Work List	19311-Scientific editor work list.pdf